Ads
related to: anti-cancer treatment
Search results
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 6 hours agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Harnessing the power of viruses to kill cancers
Medical Xpress· 6 days agoPathogens—those bugs that routinely infect and sicken us, like the common cold or influenza—are being studied in labs around the world to see if they can be used safely and effectively to attack ...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 3 days agoCaroline Germa said: "In this population, the triple combo treatment delivered significantly better...
BioInvent to Host Virtual KOL Event to Highlight Recently Presented Efficacy Data from BioInvent's...
Digital Journal· 11 hours agoLUND, SWEDEN / ACCESSWIRE / May 30, 2024 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...
Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 9 hours agoIncyte has a collaboration and license agreement with Syndax to develop and commercialize...
Unlock Holistic Wellness with Spirulina Mater: The Natural Superfood for Optimal Health and Vitality
Digital Journal· 9 hours agoAnti-Cancer Properties: Preliminary research indicates it may reduce tumor size and inhibit cancer cell growth. ...Administration. This ...
AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative...
WROC Rochester· 3 days agoNew safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation, potential best-in-class ...
No Memes, Ma'am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
InvestorPlace· 2 days agoNot long ago, GameStop (NYSE:GME) stock soared and then tanked on the meme-stock waves. A company...
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in...
WTNH-TV New Haven· 3 days ago("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement...
KTLA-TV Los Angeles· 4 days ago("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "BioNTech"), a next-generation immunotherapy company pioneering ...